Philips wins Dutch court battle over sleep apnea device recall
by@Reuters
Summary
Philips has won a legal victory in a Dutch court, which dismissed shareholder demands for an investigation into the company's handling of a massive recall of sleep apnea devices. Shareholders alleged that Philips executives responded too late to the issues linked to the recall, which affected around 15 million devices due to potentially harmful substances in the foam. However, the court found no evidence that Philips had prior knowledge of the problems before issuing warnings and concluded there was no necessity for earlier intervention by management. This recall has resulted in ongoing regulatory scrutiny in multiple countries, including France, where investigations related to safety disclosures are still active.
Tokens
$PHG
Analysis
Philips: Philips is a health technology company focused on diagnostic imaging, patient monitoring, and connected care solutions. In this case, it successfully defended against shareholder allegations of delayed response and inadequate disclosures regarding its 2021 sleep apnea device recall during a Dutch court proceeding. The Enterprise Chamber of the Amsterdam Court of Appeal ruled in its favor, finding no evidence of prior knowledge or management lapses at its Respironics subsidiary. Legal Outcome: A Dutch court dismissed shareholder demands for an inquiry into the company's handling of the sleep apnea device recall. Regulatory Scrutiny: The recall has prompted ongoing investigations into safety disclosures in multiple countries, including France.
Categories
macropolitics